Buprenorphine And Naloxone Tablet
Product Images NDC 60687-637

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 60687-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablet Blister (2 mg 0.5 mg Blister)

Label sheet showing multiple identical labels for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg, from American Health Packaging. Each label includes the product name, strength, dosage form, barcode, expiration date placeholder, lot number placeholder, and the labeler's location in Columbus, Ohio.*

FDA Label Image

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablets Carton (2 mg 0.5 mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg strength. The label shows a quantity of 50 tablets (5 blister packs of 10). It includes NDC number 60687-626-65, the Schedule III controlled substance symbol, prescription-only designation, and distributor information for American Health Packaging, Columbus, Ohio.*

FDA Label Image

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablet Blister (8 mg 2 mg Blister)

Packaging label showing multiple instances of Buprenorphine and Naloxone Sublingual Tablets, each with a strength of 8 mg/2 mg. The labels display the drug name, dosage form, strength, National Drug Code format, and the labeler, American Health Packaging, Columbus, Ohio. Each label includes barcode and placeholders for lot number and expiration date.*

FDA Label Image

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablets Cartons (8 mg 2 mg Carton)

Packaging label for Buprenorphine and Naloxone 8 mg/2 mg sublingual tablets by American Health Packaging. The label shows 50 tablets (5 x 10) with the NDC number 60687-637-65. It includes a statement for pharmacists to dispense the medication guide, a warning about tablet identification, dosage instructions, storage conditions, and child safety information. The label also displays a barcode and the Schedule III controlled substance symbol.*

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine Structure)

Chemical structure of Buprenorphine and Naloxone showing the molecular framework typical for Buprenorphine with a hydrochloride (HCl) designation. The diagram presents key functional groups and stereochemistry of the molecule.*

FDA Label Image

Naloxone Chemical Structure (Naloxone Structure)

Chemical structure of Buprenorphine hydrochloride dihydrate, showing its molecular framework with rings and functional groups.*

FDA Label Image

Place Tablets Under Tongue (Image 01)

An instructional illustration showing the placement of a sublingual tablet underneath the tongue inside an open mouth. The image demonstrates how to position the tablet for sublingual administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.